STOCK TITAN

Stryker (NYSE: SYK) CEO Kevin Lobo granted 50,332 performance-based shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stryker Corp Chair and CEO Kevin Lobo received an equity award of 50,332 shares of Common Stock on March 9, 2026 as a grant/award acquisition. The award was earned upon achieving pre-set three-year adjusted diluted net earnings per share goals and sales performance goals, and the earned shares vest on March 21, 2026.

After this award, Lobo directly holds 247,271 shares of Stryker common stock and indirectly holds 721 shares through a 401(k) plan. A one‑share adjustment corrected a previously reported balance related to an earlier option exercise and associated tax withholding.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lobo Kevin

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chair and CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/09/2026 A(1) 50,332 A $0 247,271(2) D
Common Stock 721 I By 401K
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026.
2. The balance of shares reflects an adjustment of one share from the amount previously reported to correct the number of shares that were withheld to cover the option exercise cost and tax withholding that occurred on February 6, 2026.
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Kevin A Lobo 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stryker (SYK) CEO Kevin Lobo report in this Form 4 filing?

Kevin Lobo reported receiving an equity award of 50,332 shares of Stryker Common Stock as a grant. The award reflects performance against three-year earnings and sales goals and increases his direct ownership stake in the company.

How many Stryker (SYK) shares does Kevin Lobo hold after this transaction?

After the award, Kevin Lobo directly holds 247,271 Stryker shares and indirectly holds 721 shares through a 401(k) plan. These figures show his total reported equity position following the March 9, 2026 grant.

What performance goals were tied to Kevin Lobo’s new Stryker (SYK) share award?

The 50,332-share award was earned based on pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. This links Lobo’s compensation to Stryker’s multi-year profitability and revenue achievements.

When do Kevin Lobo’s newly awarded Stryker (SYK) shares vest?

The earned 50,332 Stryker shares from Kevin Lobo’s performance-based award vest on March 21, 2026. Vesting means he fully earns the shares at that date, assuming all award conditions remain satisfied.

Was there any correction or adjustment noted in Kevin Lobo’s Stryker (SYK) holdings?

Yes. The filing notes a one-share adjustment to correct the previously reported number of shares withheld for option exercise cost and tax withholding from a February 6, 2026 transaction, updating his reported balance by a single share.
Stryker Corp

NYSE:SYK

View SYK Stock Overview

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

130.02B
361.71M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE